https://www.selleckchem.com/pr....oducts/vevorisertib-
220% (90% confidence interval 0.124-0.389), 0.298% (0.122-0.73, 0.154% (0.090-0.264), and 0.108% (0.051-0.231), respectively. With food, the A'e of formulation 1 decreased least versus fasted (-27%) compared with the A'e of formulations 2, 3, and 4 (-73%, -80%, and -65%, respectively). Formulations 1-3 disintegrated in the small intestine, formulation 4 closer to the large intestine. All GR formulations were well tolerated and in line with the known safety profile for IR risedronate. Formulation 2 had the highest
Me gusta
Comentario
Compartir
